| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 7,869 | 9,555 | ||
| Other current assets | 237 | 522 | ||
| Total current assets | 8,106 | 10,077 | ||
| Restricted cash | - | 0 | ||
| Operating lease right-of-use asset, net | 40 | 46 | ||
| Property and equipment, net | 144 | 87 | ||
| Total assets | 8,290 | 10,210 | ||
| Convertible promissory notes | - | 0 | ||
| Accounts payable | 1,709 | 2,644 | ||
| Operating lease liability, current | 28 | 27 | ||
| Promissory note | 3,031 | - | ||
| Other current liabilities | 529 | 414 | ||
| Total current liabilities | 5,297 | 3,085 | ||
| Derivative financial liabilities (note 2f and note 3b) | 3 | 5 | ||
| Operating lease liability, non-current | 12 | 19 | ||
| Loans from stockholders | 227 | 221 | ||
| Total liabilities | 5,539 | 3,330 | ||
| Common stock value 250,000,000 and 100,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 899,410 and 13,409 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 1 | 1 | ||
| Additional paid-in capital | 150,690 | 150,649 | ||
| Receipts on account of shares | 228 | 228 | ||
| Accumulated other comprehensive income | 42 | 41 | ||
| Accumulated deficit | -148,210 | -144,039 | ||
| Total stockholders equity (deficit) | 2,751 | 6,880 | ||
| Total liabilities and stockholders equity (deficit) | 8,290 | 10,210 | ||
Glucotrack, Inc. (GCTK)
Glucotrack, Inc. (GCTK)